Ic-8 Apthera Iol
Payments companies reported to CMS as associated with Ic-8 Apthera Iol. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ic-8 Apthera Iol, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ic-8 Apthera Iol
These are the largest totals companies reported as associated with Ic-8 Apthera Iol. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brenda Wahl | Indianapolis, IN | Optometrist | $38,108.76 |
| Omid Khodai | Lake Forest, CA | Optometrist | $34,650.00 |
| John Vukich | Wauwatosa, WI | Ophthalmology | $24,914.50 |
| Karl Stonecipher | Greensboro, NC | Ophthalmology | $21,558.20 |
| Elizabeth Yeu-Lin | Norfolk, VA | Ophthalmology | $18,787.09 |
| Alice Epitropoulos | Columbus, OH | Ophthalmology | $15,209.95 |
| Mark Packer | Boulder, CO | Ophthalmology | $14,294.90 |
| Mark Lobanoff | St Louis Park, MN | Ophthalmology | $14,169.51 |
| Farrell Tyson | Cape Coral, FL | Ophthalmology | $13,146.84 |
| Ravi Patel | Eatontown, NJ | Ophthalmology | $12,849.80 |
Prescribed Ic-8 Apthera Iol?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.